A Strategy of Plasma Protein Quantitation by Selective Reaction Monitoring of an Intact Protein
Authors:
- 15 November 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 75 (24) , 7008-7014
Abstract
Immunoassays are used extensively in the quantitative analysis of proteins in plasma, urine, and other biological matrixes to support preclinical and clinical studies. Although immunoassays are both sensitive and rapid, difficulties during development of these assays are compounded by the need to have a specific antibody or antigen to the protein of interest. Furthermore, calibration curves of immunoassays are inherently nonlinear, and the technique often detects many structurally related components in addition to the analyte of interest. We have developed a novel strategy of analyzing protein concentrations in plasma by utilizing 96-well solid-phase extraction and LC−MS/MS detection of the intact protein. This strategy has been successfully applied in method development and assay validation of quantitatively analyzing protein rK5 concentrations in monkey plasma samples. Additional techniques such as precolumn regeneration and column heating were also incorporated into the assay. Total run time for each sample was ∼15 min. An LLOQ of 99.2 ng/mL from a sample volume of 50 μL, corresponding to only 380 fmol (3.97 ng) of the rK5 analyte being injected onto the analytical column (assuming 100% extraction recovery), was obtained. The validated linear dynamic range was between 99.2 and 52 920.0 ng/mL, with a correlation coefficient (r2) ranging from 0.9972 and 0.9994. The intraassay CV for this assay was between 0.6 and 3.8%, and the interassay CV was between 1.7 and 3.2%. Interassay mean accuracies were between 101.5 and 104.7%. The assay has proven rugged and specific and has been employed to generate data in support of preclinical studies. This strategy for rK5 assay could be used for the development of bioanalytical assays to provide preclinical and clinical support for other protein drug candidates and, furthermore, for the validation of biomarkers discovered from proteomic research.Keywords
This publication has 8 references indexed in Scilit:
- Proteomics goes quantitative: measuring protein abundanceTrends in Biotechnology, 2002
- Modern strategies for protein quantification in proteome analysis: Advantages and limitationsMass Spectrometry Reviews, 2002
- Effect of the mobile phase composition on the separation and detection of intact proteins by reversed-phase liquid chromatography–electrospray mass spectrometryJournal of Chromatography A, 2002
- 18 O Labeling: a tool for proteomicsRapid Communications in Mass Spectrometry, 2001
- Molecular profiling of cancer and drug-induced toxicity using new proteomic technologiesCurrent Therapeutic Research, 2001
- Online Single-Step Analysis of Blood Proteins: The Transferrin StoryAnalytical Biochemistry, 2001
- High-throughput quantitative bioanalysis by LC/MS/MSBiomedical Chromatography, 2000
- Proteomics: the industrialization of protein chemistryCurrent Opinion in Biotechnology, 2000